Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up

A tétel rövid nézete
dc.contributor.authorDomingo-Domenech, Eva
dc.contributor.authorHorwitz, Steven
dc.contributor.authorPro, Barbara
dc.contributor.authorIllidge, Tim
dc.contributor.authorTrumper, Lorenz
dc.contributor.authorIyer, Swami
dc.contributor.authorAdvani, Ranjana
dc.contributor.authorBartlett, Nancy L.
dc.contributor.authorChristensen, Jacob Haaber
dc.contributor.authorKim, Won Seog
dc.contributor.authorFeldman, Tatyana
dc.contributor.authorChoi, Ilseung
dc.contributor.authorGritti, Giuseppe
dc.contributor.authorBelada, David
dc.contributor.authorShustov, Andrei
dc.contributor.authorIllés, Árpád
dc.contributor.authorZinzani, Pier Luigi
dc.contributor.authorHüttmann, Andreas
dc.contributor.authorTrneny, Marek
dc.contributor.authorLe Gouill, Steven
dc.contributor.authorJagadeesh, Deepa
dc.contributor.authorFriedberg, Jonathan W.
dc.contributor.authorLittle, Meredith
dc.contributor.authorDong, Cassie
dc.contributor.authorFanale, Michelle
dc.contributor.authorFenton, Keenan
dc.contributor.authorSavage, Kerry J.
dc.date.accessioned2025-08-07T12:47:42Z
dc.date.available2025-08-07T12:47:42Z
dc.date.issued2025
dc.date.oa2025-08-15
dc.date.pasync2025-08-15T23:11:54Z
dc.date.updated2025-08-07T12:47:42Z
dc.description.correctorkzs
dc.identifier.citationBlood Cancer Journal. -15 : 1 (2025), p. 1-5. -(cikkazonosító)129. -Blood Cancer J. - 2044-5385
dc.identifier.doihttp://dx.doi.org/10.1038/s41408-025-01329-2
dc.identifier.issn2044-5385
dc.identifier.opachttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM131823
dc.identifier.urihttps://hdl.handle.net/2437/396645
dc.identifier.wos001542583400001
dc.languageeng
dc.rights.accessopen access article
dc.rights.ownerszerző
dc.subject.mabOrvostudományok
dc.subject.mabKlinikai orvostudományok
dc.titleBrentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up
dc.typefolyóiratcikk
dc.typelevél
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
FILE_UP_0_41408_2025_Article_1329.pdf
Méret:
572.76 KB
Formátum:
Adobe Portable Document Format
Leírás:
kiadói változat
Letöltés
Gyűjtemények
Publikációs Adatbázis